Ventas, Inc.
- Jurisdiction
United States - LEI
ORQTRC074CWLT3DKHT41 - ISIN
US92276F1003 (VTR )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€9.30 527.0% overvalued - Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. Read full profile
Fundamentals
- Net revenue
€4.52B - Gross margin
20.1% - EBIT
€333.68M - EBIT margin
7.4% - Net income
€64.89M - Net margin
1.4%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
- Last dividend amount
-
$0.48 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
754.7%
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Earl Blumenauer | October 8, 2024 | $15.00K–$50.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Sell |
| Ray Dalio |
|
|
|
Buy |
Earnings Calls
Latest earnings call: May 2, 2024 (Q1 2024)